Nodality Launches PathProa Product Line Based on Leading Single...

Nodality, Inc., which is focused on solving drug development challenges, announced today the launch of its PathPro product line. PathPro products leverage the unique capabilities of Nodality's proprietary Single Cell Network Profiling technology, offering predefined multiparametric flow cytometry-based experimental panels.

http://ift.tt/1wqxmWp